September 05, 2025

Extended-Release Risperidone Injection Receives FDA Approval

FDA approves Amneal’s risperidone extended-release injection for schizophrenia and Bipolar I maintenance.

Conexiant

September 05, 2025

Review Finds Misdiagnosis and Referral Delays in Endometriosis

Symptom dismissal, misdiagnosis, and long waits for referral contribute to delays in diagnosis and treatment.

Conexiant

September 05, 2025

Is Prenatal Chlorpyrifos Exposure Linked to Brain Changes?

Prenatal chlorpyrifos associated with magnetic resonance imaging changes, hypoperfusion, and motor slowing—without age/sex moderation, mediation, or connectivity effects.

Conexiant

September 05, 2025

Do Psychiatric Disorders Worsen Takotsubo?

Study reveals elevated cardiac pressures and stress markers in patients with mental health conditions

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 04, 2025

Persistent Grief Symptoms and Higher Mortality

Grief symptom trajectories serve as early indicators of future health care use, psychotropic medication needs, and mortality risk in bereaved individuals.

Conexiant

September 04, 2025

Less TV Time May Lower Depression Risk

Compositional data analysis reveals age-specific benefits of reallocating TV-watching time to other activities, including physical activity and sleep.

Conexiant

September 03, 2025

Fast ADHD Prescribing Seen in Young Kids

How quickly are ADHD meds started in preschool primary care?

Conexiant

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News